Evidence map›Paper›PMID 36087425›Full record

ReviewEuropean journal of radiology2022

Breast dosimetry in alternative X-ray-based imaging modalities used in current clinical practices.

S Di Maria, S Vedantham, P Vaz

Open access · greenAbstract readReview
In one paragraph

Review in European journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Serum Direct Bilirubin as a Biomarker for Breast Cancer.Breast cancer (Dove Medical Press) · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution.

S Di MariaCentro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Campus Tecnológico e Nuclear, Estrada Nacional 10, km 139,7, 2695-066 Bobadela LRS, Portugal. Electronic address: salvatore@ctn.tecnico.ulisboa.pt.
S VedanthamDepartment of Medical Imaging, The University of Arizona, Tucson, AZ, USA; Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, USA.
P VazCentro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Campus Tecnológico e Nuclear, Estrada Nacional 10, km 139,7, 2695-066 Bobadela LRS, Portugal.
Instituto Superior Técnico

Funding

Towards screening with high-resolution, low-dose, dedicated breast CTR01CA199044 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SRINIVASAN VEDANTHAM · 2016 to 2026
$6.1M
Upright, Low-dose, High-resolution, 3D Breast CTR01CA241709 · NCI · UNIVERSITY OF ARIZONA · PI VEDANTHAM, SRINIVASAN · 2019 to 2023
$3.6M
NCI NIH HHS R01 CA199044NCI NIH HHS R01 CA241709
6 · The paper itself

Abstract

In X-ray breast imaging, Digital Mammography (DM) and Digital Breast Tomosynthesis (DBT), are the standard and largely used techniques, both for diagnostic and screening purposes. Other techniques, such as dedicated Breast Computed Tomography (BCT) and Contrast Enhanced Mammography (CEM) have been developed as an alternative or a complementary technique to the established ones. The performance of these imaging techniques is being continuously assessed to improve the image quality and to reduce the radiation dose. These imaging modalities are predominantly used in the diagnostic setting to resolve incomplete or indeterminate findings detected with conventional screening examinations and could potentially be used either as an adjunct or as a primary screening tool in select populations, such as for women with dense breasts. The aim of this review is to describe the radiation dosimetry for these imaging techniques, and to compare the mean glandular dose with standard breast imaging modalities, such as DM and DBT.

Indexed as

BreastBreast NeoplasmsBreast DensityFemaleHumansMammographyRadiometryX-RaysBreast Computed TomographyBreast dosimetryContrast Enhanced MammographyMean Glandular Dose

Identifiers

PMID36087425
PMCPMC9851082
OpenAlexW4295106604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.